Skip to main content
Top
Published in: BMC Surgery 1/2020

Open Access 01-12-2020 | Gastrectomy | Research article

Implementation of minimally invasive gastrectomy for gastric cancer in a western tertiary referral center

Authors: Andrianos Tsekrekos, Tania Triantafyllou, Fredrik Klevebro, Masaru Hayami, Mats Lindblad, Magnus Nilsson, Lars Lundell, Ioannis Rouvelas

Published in: BMC Surgery | Issue 1/2020

Login to get access

Abstract

Background

Minimally invasive techniques have gradually come to take a leading position in the surgical treatment of gastrointestinal malignancies. In order to define an effective process for the implementation of similar techniques in the treatment of gastric cancer, patient caseload represents a pivotal factor for education and training, but is a prerequisite not fulfilled in most Western countries. Additionally, as opposed to the East, a variety of additional factors such as the usually advanced stage of the disease and differences in patient characteristics are prevailing and raise further obstacles. Hereby we report a strategy for a safe and effective process for the implementation of laparoscopic gastric cancer surgery in a Western tertiary referral center.

Methods

The present study describes the stepwise implementation of laparoscopic gastrectomy for the treatment of gastric cancer at a tertiary referral center, comprising the time period 2012–2019. This process was facilitated by a close collaboration with two high-volume centers in Japan, as well as exchanging fellowships and observerships between the Karolinska University Hospital and other European centers. From the initially strict selection of cases for laparoscopic surgery, laparoscopic gastrectomy has gradually become the preferred approach also in patients with locally advanced tumors.

Results

From January 1st 2010 until December 31st 2019, 249 patients were operated for gastric cancer, of whom 141 (56.6%) had an open and 108 (43.4%) a laparoscopic procedure. In the latter group, total gastrectomy was performed in 33.3% of the patients. While blood loss, operation time and length of stay decreased during the first years after implementation, these variables increased slightly during the last years of the study period, probably due to the higher proportion of advanced gastric cancer cases, as well as the higher rate of laparoscopic total gastrectomy with more extended lymphadenectomy.

Conclusions

Laparoscopic surgery is currently a valid therapeutic option for gastric cancer, which has expanded to also embrace total gastrectomy and locally advanced tumors. Collaboration between centers in the East and West, centralization to high-volume centers and application of enhanced recovery protocols are essential components in the implementation and further refinement of minimally invasive gastrectomy.
Literature
1.
go back to reference Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53.CrossRef Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53.CrossRef
2.
go back to reference Hatta W, Gotoda T, Koike T, Masamune A. History and future perspectives in Japanese guidelines for endoscopic resection of early gastric cancer. Dig Endosc. 2019;32:180–90.CrossRef Hatta W, Gotoda T, Koike T, Masamune A. History and future perspectives in Japanese guidelines for endoscopic resection of early gastric cancer. Dig Endosc. 2019;32:180–90.CrossRef
4.
go back to reference Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v38–49.CrossRef Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v38–49.CrossRef
5.
go back to reference Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75.
6.
go back to reference Oh Y, Kim MS, Lee YT, Lee CM, Kim JH, Park S. Laparoscopic total gastrectomy as a valid procedure to treat gastric cancer option both in early and advanced stage: a systematic review and meta-analysis. Eur J Surg Oncol. 2020;46(1):33–43.CrossRef Oh Y, Kim MS, Lee YT, Lee CM, Kim JH, Park S. Laparoscopic total gastrectomy as a valid procedure to treat gastric cancer option both in early and advanced stage: a systematic review and meta-analysis. Eur J Surg Oncol. 2020;46(1):33–43.CrossRef
7.
go back to reference Kim SH, Chung Y, Kim YH, Choi SI. Oncologic outcomes after laparoscopic and open distal Gastrectomy for advanced gastric Cancer: propensity score matching analysis. J Gastric Cancer. 2019;19(1):83–91.CrossRef Kim SH, Chung Y, Kim YH, Choi SI. Oncologic outcomes after laparoscopic and open distal Gastrectomy for advanced gastric Cancer: propensity score matching analysis. J Gastric Cancer. 2019;19(1):83–91.CrossRef
8.
go back to reference Nilsson M, Kamiya S, Lindblad M, Rouvelas I. Implementation of minimally invasive esophagectomy in a tertiary referral center for esophageal cancer. J Thorac Dis. 2017;9(Suppl 8):S817–s25.CrossRef Nilsson M, Kamiya S, Lindblad M, Rouvelas I. Implementation of minimally invasive esophagectomy in a tertiary referral center for esophageal cancer. J Thorac Dis. 2017;9(Suppl 8):S817–s25.CrossRef
9.
go back to reference Haverkamp L, Weijs TJ, van der Sluis PC, van der Tweel I, Ruurda JP, van Hillegersberg R. Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis. Surg Endosc. 2013;27(5):1509–20.CrossRef Haverkamp L, Weijs TJ, van der Sluis PC, van der Tweel I, Ruurda JP, van Hillegersberg R. Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis. Surg Endosc. 2013;27(5):1509–20.CrossRef
10.
go back to reference Dulucq JL, Wintringer P, Stabilini C, Solinas L, Perissat J, Mahajna A. Laparoscopic and open gastric resections for malignant lesions: a prospective comparative study. Surg Endosc. 2005;19(7):933–8.CrossRef Dulucq JL, Wintringer P, Stabilini C, Solinas L, Perissat J, Mahajna A. Laparoscopic and open gastric resections for malignant lesions: a prospective comparative study. Surg Endosc. 2005;19(7):933–8.CrossRef
11.
go back to reference Topal B, Leys E, Ectors N, Aerts R, Penninckx F. Determinants of complications and adequacy of surgical resection in laparoscopic versus open total gastrectomy for adenocarcinoma. Surg Endosc. 2008;22(4):980–4.CrossRef Topal B, Leys E, Ectors N, Aerts R, Penninckx F. Determinants of complications and adequacy of surgical resection in laparoscopic versus open total gastrectomy for adenocarcinoma. Surg Endosc. 2008;22(4):980–4.CrossRef
12.
go back to reference Irino T, Tsai JA, Ericson J, Nilsson M, Lundell L, Rouvelas I. Thoracoscopic side-to-side esophagogastrostomy by use of linear stapler-a simplified technique facilitating a minimally invasive Ivor-Lewis operation. Langenbecks Arch Surg. 2016;401(3):315–22.CrossRef Irino T, Tsai JA, Ericson J, Nilsson M, Lundell L, Rouvelas I. Thoracoscopic side-to-side esophagogastrostomy by use of linear stapler-a simplified technique facilitating a minimally invasive Ivor-Lewis operation. Langenbecks Arch Surg. 2016;401(3):315–22.CrossRef
13.
go back to reference Terashima M, Doki Y, Kurokawa Y, Mizusawa J, Katai H, Yoshikawa T, et al. Primary results of a phase III trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001). J Clin Oncol. 2017;35(4_suppl):5.CrossRef Terashima M, Doki Y, Kurokawa Y, Mizusawa J, Katai H, Yoshikawa T, et al. Primary results of a phase III trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001). J Clin Oncol. 2017;35(4_suppl):5.CrossRef
14.
go back to reference Kim HH, Han SU, Kim MC, Kim W, Lee HJ, Ryu SW, Korean Laparoendoscopic Gastrointestinal Surgery Study (KLASS) Group, et al. Effect of laparoscopic distal Gastrectomy vs open distal Gastrectomy on long-term survival among patients with stage I gastric Cancer: the KLASS-01 randomized clinical trial. JAMA Oncol. 2019;5(4):506–13.CrossRef Kim HH, Han SU, Kim MC, Kim W, Lee HJ, Ryu SW, Korean Laparoendoscopic Gastrointestinal Surgery Study (KLASS) Group, et al. Effect of laparoscopic distal Gastrectomy vs open distal Gastrectomy on long-term survival among patients with stage I gastric Cancer: the KLASS-01 randomized clinical trial. JAMA Oncol. 2019;5(4):506–13.CrossRef
15.
go back to reference Katai H, Mizusawa J, Katayama H, Morita S, Yamada T, Bando E, et al. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol. 2020;5(2):142–51.CrossRef Katai H, Mizusawa J, Katayama H, Morita S, Yamada T, Bando E, et al. Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol. 2020;5(2):142–51.CrossRef
16.
go back to reference Yu J, Huang C, Sun Y, Su X, Cao H, Hu J, Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group, et al. Effect of laparoscopic vs open distal Gastrectomy on 3-year disease-free survival in patients with locally advanced gastric Cancer: the CLASS-01 randomized clinical trial. JAMA. 2019;321(20):1983–92.CrossRef Yu J, Huang C, Sun Y, Su X, Cao H, Hu J, Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group, et al. Effect of laparoscopic vs open distal Gastrectomy on 3-year disease-free survival in patients with locally advanced gastric Cancer: the CLASS-01 randomized clinical trial. JAMA. 2019;321(20):1983–92.CrossRef
17.
go back to reference Lee HJ, Hyung WJ, Yang HK, Han SU, Park YK, An JY, Korean Laparo-endoscopic Gastrointestinal Surgery Study (KLASS) Group, et al. Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal Gastrectomy with D2 lymphadenectomy to open distal Gastrectomy for locally advanced gastric Cancer (KLASS-02-RCT). Ann Surg. 2019;270(6):983–91.CrossRef Lee HJ, Hyung WJ, Yang HK, Han SU, Park YK, An JY, Korean Laparo-endoscopic Gastrointestinal Surgery Study (KLASS) Group, et al. Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal Gastrectomy with D2 lymphadenectomy to open distal Gastrectomy for locally advanced gastric Cancer (KLASS-02-RCT). Ann Surg. 2019;270(6):983–91.CrossRef
18.
go back to reference Inaki N, Etoh T, Ohyama T, Uchiyama K, Katada N, Koeda K, et al. A multi-institutional, prospective, phase II feasibility study of laparoscopy-assisted distal Gastrectomy with D2 lymph node dissection for locally advanced gastric Cancer (JLSSG0901). World J Surg. 2015;39(11):2734–41.CrossRef Inaki N, Etoh T, Ohyama T, Uchiyama K, Katada N, Koeda K, et al. A multi-institutional, prospective, phase II feasibility study of laparoscopy-assisted distal Gastrectomy with D2 lymph node dissection for locally advanced gastric Cancer (JLSSG0901). World J Surg. 2015;39(11):2734–41.CrossRef
19.
go back to reference Sakamoto T, Fujiogi M, Matsui H, Fushimi K, Yasunaga H. Short-term outcomes of laparoscopic and open Total Gastrectomy for gastric Cancer: a Nationwide retrospective cohort analysis. Ann Surg Oncol. 2020;27(2):518–26.CrossRef Sakamoto T, Fujiogi M, Matsui H, Fushimi K, Yasunaga H. Short-term outcomes of laparoscopic and open Total Gastrectomy for gastric Cancer: a Nationwide retrospective cohort analysis. Ann Surg Oncol. 2020;27(2):518–26.CrossRef
20.
go back to reference Gertsen EC, Brenkman HJF, Seesing MFJ, Goense L, Ruurda JP, van Hillegersberg R, Dutch Upper Gastrointestinal Cancer Audit (DUCA) Group. Introduction of minimally invasive surgery for distal and total gastrectomy: a population-based study. Eur J Surg Oncol. 2019;45(3):403–9.CrossRef Gertsen EC, Brenkman HJF, Seesing MFJ, Goense L, Ruurda JP, van Hillegersberg R, Dutch Upper Gastrointestinal Cancer Audit (DUCA) Group. Introduction of minimally invasive surgery for distal and total gastrectomy: a population-based study. Eur J Surg Oncol. 2019;45(3):403–9.CrossRef
21.
go back to reference He H, Li H, Su X, Li Z, Yu P, Huang H, Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group, et al. Study on safety of laparoscopic total gastrectomy for clinical stage I gastric cancer: the protocol of the CLASS02–01 multicenter randomized controlled clinical trial. BMC Cancer. 2018;18(1):944.CrossRef He H, Li H, Su X, Li Z, Yu P, Huang H, Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group, et al. Study on safety of laparoscopic total gastrectomy for clinical stage I gastric cancer: the protocol of the CLASS02–01 multicenter randomized controlled clinical trial. BMC Cancer. 2018;18(1):944.CrossRef
23.
go back to reference Griffin SM. Gastric cancer in the east: same disease, different patient. Br J Surg. 2005;92(9):1055–6.CrossRef Griffin SM. Gastric cancer in the east: same disease, different patient. Br J Surg. 2005;92(9):1055–6.CrossRef
24.
go back to reference van der Wielen N, Straatman J, Cuesta MA, Daams F, van der Peet DL. Short-term outcomes in minimally invasive versus open gastrectomy: the differences between east and west. A systematic review of the literature. Gastric Cancer. 2018;21(1):19–30.CrossRef van der Wielen N, Straatman J, Cuesta MA, Daams F, van der Peet DL. Short-term outcomes in minimally invasive versus open gastrectomy: the differences between east and west. A systematic review of the literature. Gastric Cancer. 2018;21(1):19–30.CrossRef
25.
go back to reference Chevallay M, Jung M, Berlth F, Seung-Hun C, Morel P, Mönig S. Laparoscopic surgery for gastric Cancer: the European point of view. J Oncol. 2019;2019:8738502.CrossRef Chevallay M, Jung M, Berlth F, Seung-Hun C, Morel P, Mönig S. Laparoscopic surgery for gastric Cancer: the European point of view. J Oncol. 2019;2019:8738502.CrossRef
26.
go back to reference Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, FLOT4-AIO Investigators, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393(10184):1948–57.CrossRef Al-Batran SE, Homann N, Pauligk C, Goetze TO, Meiler J, Kasper S, FLOT4-AIO Investigators, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393(10184):1948–57.CrossRef
27.
go back to reference Li Z, Shan F, Ying X, Zhang Y, Jian-Yu E, Wang Y, et al. Assessment of laparoscopic distal gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: a randomized clinical trial. JAMA Surg. 2019;154:1093–101.CrossRef Li Z, Shan F, Ying X, Zhang Y, Jian-Yu E, Wang Y, et al. Assessment of laparoscopic distal gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: a randomized clinical trial. JAMA Surg. 2019;154:1093–101.CrossRef
28.
go back to reference Haverkamp L, Brenkman HJ, Seesing MF, Gisbertz SS, van Berge Henegouwen MI, Luyer MD, LOGICA Study gGoup, et al. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer. 2015;15:556.CrossRef Haverkamp L, Brenkman HJ, Seesing MF, Gisbertz SS, van Berge Henegouwen MI, Luyer MD, LOGICA Study gGoup, et al. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer. 2015;15:556.CrossRef
29.
go back to reference Straatman J, van der Wielen N, Cuesta MA, Gisbertz SS, Hartemink KJ, Alonso Poza A, et al. Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial. Trials. 2015;16:123.CrossRef Straatman J, van der Wielen N, Cuesta MA, Gisbertz SS, Hartemink KJ, Alonso Poza A, et al. Surgical techniques, open versus minimally invasive gastrectomy after chemotherapy (STOMACH trial): study protocol for a randomized controlled trial. Trials. 2015;16:123.CrossRef
30.
go back to reference Kurokawa Y, Doki Y, Mizusawa J, Terashima M, Katai H, Yoshikawa T, et al. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol. 2018;3(7):460–8.CrossRef Kurokawa Y, Doki Y, Mizusawa J, Terashima M, Katai H, Yoshikawa T, et al. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial. Lancet Gastroenterol Hepatol. 2018;3(7):460–8.CrossRef
31.
go back to reference Sano T, Sasako M, Mizusawa J, Yamamoto S, Katai H, Yoshikawa T, Stomach Cancer Study Group of the Japan Clinical Oncology Group, et al. Randomized controlled trial to evaluate Splenectomy in Total Gastrectomy for proximal gastric carcinoma. Ann Surg. 2017;265(2):277–83.CrossRef Sano T, Sasako M, Mizusawa J, Yamamoto S, Katai H, Yoshikawa T, Stomach Cancer Study Group of the Japan Clinical Oncology Group, et al. Randomized controlled trial to evaluate Splenectomy in Total Gastrectomy for proximal gastric carcinoma. Ann Surg. 2017;265(2):277–83.CrossRef
32.
go back to reference Tsekrekos A, Klevebro F, Hayami M, Kamiya S, Lindblad M, Nilsson M, et al. Laparoscopic versus open Gastrectomy for Cancer: a Western center cohort study. J Surg Res. 2020;247:372–9.CrossRef Tsekrekos A, Klevebro F, Hayami M, Kamiya S, Lindblad M, Nilsson M, et al. Laparoscopic versus open Gastrectomy for Cancer: a Western center cohort study. J Surg Res. 2020;247:372–9.CrossRef
33.
go back to reference Mori T, Kimura T, Kitajima M. Skill accreditation system for laparoscopic gastroenterologic surgeons in Japan. Minim Invasive Ther Allied Technol. 2010;19(1):18–23.CrossRef Mori T, Kimura T, Kitajima M. Skill accreditation system for laparoscopic gastroenterologic surgeons in Japan. Minim Invasive Ther Allied Technol. 2010;19(1):18–23.CrossRef
Metadata
Title
Implementation of minimally invasive gastrectomy for gastric cancer in a western tertiary referral center
Authors
Andrianos Tsekrekos
Tania Triantafyllou
Fredrik Klevebro
Masaru Hayami
Mats Lindblad
Magnus Nilsson
Lars Lundell
Ioannis Rouvelas
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2020
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-020-00812-w

Other articles of this Issue 1/2020

BMC Surgery 1/2020 Go to the issue